This June, Canadians from coast to coast will be coming together to unite, raise funds and help accelerate the pace of type 1 diabetes (T1D) research as part of the […]
Our families are thinking ‘100’ to commemorate 100 years of insulin
Federal Budget Includes New Funding for Type 1 Diabetes Research, National Diabetes Framework and Expanded Access to Disability Tax Credit
JDRF Canada is thrilled that federal budget 2021 includes new funding for type 1 diabetes research, as well as support for a national diabetes framework and improvements to the Disability […]
Commemorating the 100th Anniversary of the Discovery of Insulin
May 4th, 2021 “Insulin is not a cure for diabetes; it is a treatment.” – Dr. Frederick Banting 2021 marks the 100th anniversary of the discovery of insulin by researchers […]
COVID-19 and T1D – Together, We Can Keep Our Community Safe
Update: May 3, 2021: Ontario: As of May 10, 2021 anyone over 16 with type 1 diabetes can book a vaccine throughout the province. Alberta: Children aged 12 -15 with type 1 […]
FDA Designates TTP399 a Breakthrough Therapy for People Living with T1D
May 4th, 2021 On April 15, 2021 the U.S. Food and Drug Administration (FDA) granted breakthrough therapy designation for vTv Therapeutics’ TTP399 as an adjunct therapy to insulin for type 1 diabetes […]
JDRF recognizes its volunteers for National Volunteer Week 2021 – April 18-24, 2021
April 19, 2021 JDRF was founded over 40 years by a group of devoted parents to provide a voice for the type 1 diabetes (T1D) community – and with the […]
Honouring our JDRF Volunteers at the Ontario Volunteer Service Awards
April 9, 2021 Volunteers can often be unsung heroes of an organization, but they help drive a mission forward with unparalleled dedication and perseverance, especially the volunteers at JDRF. And […]
Beyond Insulin™ invests $25,600 in CREATE
100 years after the discovery of insulin, JDRF is pleased to announce the results of the first annual Beyond Insulin Vote for Research.
Bringing Progress to Life: Type 1 Diabetes Research Symposium
JDRF’s mission of improving lives and curing type 1 diabetes (T1D) cannot be achieved alone. It requires us to engage with stakeholders who believe in what we have set out to do and are able to help drive our mission forward – and this group includes regulators. JDRF recognizes the importance of engaging with regulators in order to to help shape and provide clear and reasonable pathways to scientific research and therapy approvals for T1D treatment and cure therapies.
Bringing Breakthroughs to Life: Type 1 Diabetes Research Symposium
JDRF’s mission of improving lives and curing type 1 diabetes (T1D) cannot be achieved alone. It requires us to engage with stakeholders who believe in what we have set out […]
Thriving with Diabetes
Halloween day will never be the same for Conrad Pow as that was the day in 2018 when his daughter Chloe was diagnosed with type 1 diabetes (T1D).
British Columbians speak out about #AccessForAll in online community consultations
This past month, as part of JDRF’s #AccessforAll campaign, British Columbians impacted by type 1 diabetes (T1D) came together with patient advocates, clinicians and elected officials to discuss the benefits of continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) devices, and the need to cover these technologies under B.C. Pharmacare.
